🔎 Trials Near Me

Akèy › Migrèn › Texas › Houston

Etid klinik pou Migrèn nan Houston, TX

7 etid pou Migrèn ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of EVO756 in Adults With Migraine

Ap rekriteFaz 2
  • SFF Medical Research Group LLC, Houston
  • Mercury Clinical Research Inc. - Houston Neurology Associates, Houston
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT07616128

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Ap rekriteFaz 3
  • DM Clinical Research - Cy Fair, Houston
  • SCLA Management - Drop Box, Houston
  • SCLA Management Office, Houston
  • ak 1 plis
Laj 6 a 17 · Tout sèks · Mizajou Sep 28, 2026 · NCT05156398

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Pain and Headache Centers of Texas, Houston
  • SCLA Management, Houston
  • NeuroCare Plus, Houston
  • ak 1 plis
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Ap rekriteFaz 3
  • UTHealth Houston, Houston
  • Pain and Headache Centers of Texas, Houston
  • SCLA Management, Houston
  • ak 2 plis
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Ap rekriteFaz 3
  • Earle Research /ID# 270424, Houston
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Ap rekriteFaz 3
  • DM Clinical Research /ID# 229826, Houston
  • Aavon Clinical Trials /ID# 279007, Houston
  • Houston Clinical Research Associates /ID# 244889, Houston
  • ak 1 plis
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Ap rekriteFaz 3
  • Victorium Clinical Research, Houston
  • DM Clinical Research, Houston
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Etid Migrèn nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.